Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
p decrease » _ decrease (Expand Search), pa decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
p decrease » _ decrease (Expand Search), pa decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1541
related to Fig 4. ROS, K+ efflux and cathepsin B do not affect TNFα production in response to eggs.
Published 2025Subjects: -
1542
-
1543
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1544
-
1545
-
1546
-
1547
-
1548
-
1549
ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.
Published 2025Subjects: -
1550
-
1551
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1552
-
1553
-
1554
Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.
Published 2025Subjects: -
1555
BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.
Published 2025Subjects: -
1556
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1557
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
1558
-
1559
The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).
Published 2025Subjects: -
1560